Rainbow Childrens Medicare Limited (IN:RAINBOW)
:RAINBOW
Want to see IN:RAINBOW full AI Analyst Report?
Top Page
Rainbow Childrens Medicare Limited
(RAINBOW)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹1,263.00
▼(-6.36% Downside)
Action:ReiteratedDate:10/22/25
Rainbow Childrens Medicare Limited's overall stock score is primarily driven by its strong financial performance, characterized by robust revenue growth and solid cash flow generation. However, the technical analysis indicates a bearish trend, and the high P/E ratio suggests potential overvaluation, which negatively impacts the overall score.
Positive Factors
Sustained Revenue Growth
Multi-year revenue growth of this magnitude reflects durable demand for Rainbow’s pediatric and maternal tertiary/quaternary services. Structural expansion in patient volumes and higher-acuity care supports sustainable top-line momentum, enabling scale benefits and continued reinvestment in clinical capabilities over 2–6 months and beyond.
Negative Factors
Rising Total Liabilities
A trend of increasing liabilities, even from a manageable base, can erode financial flexibility over time by increasing interest and repayment obligations. If liabilities continue to rise it could constrain free cash flow available for reinvestment, slow expansion plans, or force higher-cost funding choices.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
Multi-year revenue growth of this magnitude reflects durable demand for Rainbow’s pediatric and maternal tertiary/quaternary services. Structural expansion in patient volumes and higher-acuity care supports sustainable top-line momentum, enabling scale benefits and continued reinvestment in clinical capabilities over 2–6 months and beyond.
Read all positive factors
Rainbow Childrens Medicare Limited (RAINBOW) vs. iShares MSCI India ETF (INDA)
Market Cap
₹128.50B
Dividend Yield0.22%
Average Volume (3M)8.91K
Price to Earnings (P/E)46.2
Beta (1Y)0.48
Revenue Growth9.91%
EPS Growth9.57%
CountryIN
Employees3,940
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)7.10
Shares Outstanding101,559,160
10 Day Avg. Volume4,219
30 Day Avg. Volume8,914
Financial Highlights & Ratios
PEG Ratio4.75
Price to Book (P/B)9.54
Price to Sales (P/S)9.24
P/FCF Ratio56.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)32.32
Revenue Forecast (FY)₹19.88B
Rainbow Childrens Medicare Limited Business Overview & Revenue Model
Company Description
Rainbow Children's Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company's child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver disea...
How the Company Makes Money
RAINBOW primarily makes money by providing healthcare services to patients through its hospitals and clinics. Key revenue streams typically include (1) in-patient services (room/bed charges, nursing, ICU/NICU care, procedure and operating theatre ...
Rainbow Childrens Medicare Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.66B | 15.16B | 12.97B | 11.74B | 9.74B | 6.50B |
| Gross Profit | 8.41B | 10.82B | 9.31B | 8.44B | 6.44B | 4.24B |
| EBITDA | 4.99B | 4.37B | 3.90B | 3.65B | 2.73B | 1.35B |
| Net Income | 2.54B | 2.43B | 2.17B | 2.11B | 1.38B | 400.18M |
Balance Sheet | ||||||
| Total Assets | 25.87B | 23.77B | 21.70B | 17.76B | 14.24B | 10.81B |
| Cash, Cash Equivalents and Short-Term Investments | 4.42B | 6.94B | 5.02B | 3.81B | 2.03B | 1.03B |
| Total Debt | 8.16B | 7.64B | 7.65B | 5.70B | 5.79B | 5.18B |
| Total Liabilities | 10.54B | 9.02B | 9.05B | 7.06B | 6.89B | 6.33B |
| Stockholders Equity | 15.18B | 14.68B | 12.59B | 10.60B | 6.03B | 4.46B |
Cash Flow | ||||||
| Free Cash Flow | -946.85M | 2.50B | -321.75M | 1.86B | 1.62B | 666.11M |
| Operating Cash Flow | 2.08B | 3.96B | 3.21B | 3.27B | 2.24B | 1.43B |
| Investing Cash Flow | -1.25B | -2.68B | -2.26B | -4.65B | -1.75B | -828.80M |
| Financing Cash Flow | -762.19M | -1.18B | -1.02B | 1.43B | -440.62M | -608.73M |
Rainbow Childrens Medicare Limited Technical Analysis
Positive
1348.80
Price Trends
1182.01
Positive
1244.81
Positive
1350.70
Negative
Market Momentum
23.97
Negative
61.31
Neutral
72.92
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RAINBOW, the sentiment is Positive. The current price of 1348.8 is above the 20-day moving average (MA) of 1181.61, above the 50-day MA of 1182.01, and below the 200-day MA of 1350.70, indicating a neutral trend. The MACD of 23.97 indicates Negative momentum. The RSI at 61.31 is Neutral, neither overbought nor oversold. The STOCH value of 72.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:RAINBOW.
Rainbow Childrens Medicare Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ₹31.73B | 43.39 | ― | 0.85% | ― | ― | |
67 Neutral | ₹83.78B | -247.47 | ― | ― | 17.58% | -38.20% | |
67 Neutral | ₹21.03B | 38.21 | ― | 0.16% | 17.05% | 56.84% | |
66 Neutral | ₹128.50B | 46.21 | ― | 0.22% | 9.91% | 9.57% | |
62 Neutral | ₹144.25B | 76.03 | ― | 0.46% | 10.09% | -19.40% | |
58 Neutral | ₹19.60B | 38.37 | ― | 0.38% | 11.51% | 21.56% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:RAINBOW
Rainbow Childrens Medicare Limited
1,256.85
-242.07
-16.15%
IN:HCG
HealthCare Global Enterprises Ltd.
566.80
-23.25
-3.94%
IN:JUBLPHARMA
Jubilant Pharmova Limited
905.05
-10.04
-1.10%
IN:KRSNAA
Krsnaa Diagnostics Limited
616.15
-184.07
-23.00%
IN:RPGLIFE
RPG Life Sciences Limited
1,899.80
-275.70
-12.67%
IN:VIMTALABS
Vimta Labs Limited
472.85
-12.26
-2.53%
Rainbow Childrens Medicare Limited Corporate Events
Rainbow Children’s Medicare Files SEBI Regulation 74(5) Compliance Certificate
Apr 7, 2026
Rainbow Children’s Medicare Limited has submitted to NSE and BSE a compliance certificate obtained from its registrar and share transfer agent, KFIN Technologies Limited, under Regulation 74(5) of the SEBI (Depositories and Participants) Reg...
Rainbow Children’s Medicare Expands Bengaluru Footprint with New 90-Bed Hospital in Electronic City
Jan 28, 2026
Rainbow Children’s Medicare Limited has inaugurated a new 90-bed spoke hospital in Electronic City, Bengaluru, increasing its total capacity to approximately 2,375 beds across India. The ₹55 crore facility, funded through internal accr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.